Controlled release of liraglutide using thermogelling polymers in treatment of diabetes

Yipei Chen,Yuzhuo Li,Wenjia Shen,Kun Li,Lin Yu,Qinghua Chen,Jiandong Ding
DOI: https://doi.org/10.1038/srep31593
IF: 4.6
2016-08-17
Scientific Reports
Abstract:Abstract In treatment of diabetes, it is much desired in clinics and challenging in pharmaceutics and material science to set up a long-acting drug delivery system. This study was aimed at constructing a new delivery system using thermogelling PEG/polyester copolymers. Liraglutide, a fatty acid-modified antidiabetic polypeptide, was selected as the model drug. The thermogelling polymers were presented by poly(ε-caprolactone- co -glycolic acid)-poly(ethylene glycol)-poly(ε-caprolactone- co -glycolic acid) (PCGA-PEG-PCGA) and poly(lactic acid- co -glycolic acid)-poly(ethylene glycol)-poly(lactic acid- co -glycolic acid) (PLGA-PEG-PLGA). Both the copolymers were soluble in water and their concentrated solutions underwent temperature-induced sol-gel transitions. The drug-loaded polymer solutions were injectable at room temperature and gelled in situ at body temperature. Particularly, the liraglutide-loaded PCGA-PEG-PCGA thermogel formulation exhibited a sustained drug release manner over one week in both in vitro and in vivo tests. This feature was attributed to the combined effects of an appropriate drug/polymer interaction and a high chain mobility of the carrier polymer, which facilitated the sustained diffusion of drug out of the thermogel. Finally, a single subcutaneous injection of this formulation showed a remarkably improved glucose tolerance of mice for one week. Hence, the present study not only developed a promising long-acting antidiabetic formulation, but also put forward a combined strategy for controlled delivery of polypeptide.
multidisciplinary sciences
What problem does this paper attempt to address?